Physician

Ademola Bello, M.D.

According to 2025 Medicare claims, Ademola Bello, M.D. (NPI: 1053609339) practices psychiatry in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is HR PHYSICIAN SERVICES (NPI: 1881696698; TIN: 232696460) and primary practice location at 19046-8001.

Bello's data goes back to 2015 and runs through 2024. For example, in 2023, this provider had 34 traditional Medicare patients, billed 149 HCPCS/CPT codes, and received $9,320 in Medicare payments. 2024 Part D data shows 256 prescription claims across 18 beneficiaries totaling $7,687 in drug costs, led by Levetiracetam (Levetiracetam). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $19,506 to $9,320. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $45,281 to $7,687. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	86	397	$19,506
2016	188	919	$43,637
2017	194	834	$41,888
2018	86	262	$15,537
2019	48	137	$7,635
2020	20	43	$2,731
2021	33	176	$10,221
2022	38	156	$8,615
2023	34	149	$9,320
2024	N/R	N/R	N/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	57	267	$45,281
2016	87	353	$25,554
2017	54	243	$17,421
2018	21	278	$24,764
2019	15	192	$12,536
2020	N/R	N/R	N/R
2021	N/R	29	$20,545
2022	N/R	33	$10,107
2023	24	92	$4,633
2024	18	256	$7,687

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Levetiracetam	Levetiracetam	18	420	$687
Risperidone	Risperidone	13	384	$318
Benztropine Mesylate	Benztropine Mesylate	27	682	$256
Oxcarbazepine	Oxcarbazepine	15	322	$163
Lorazepam	Lorazepam	14	329	$104

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Ademola Bello, M.D.?

Tedicare shows public-source Medicare data for Ademola Bello, M.D. (NPI 1053609339), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ademola Bello, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ademola Bello, M.D.?

Ademola Bello, M.D. is linked to HR PHYSICIAN SERVICES (billing NPI 1881696698) in the available physician profile data.

Does Ademola Bello, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.